Early Events of Fusion Between Epstein Barr Virus and Human Lymphoblastoid Cells (Raji) Detected by R18 Fluorescence Dequenching Measurements

References

• Baichwal V., Sudgen B. Latency comes of age for herpesvirus. Cell 1988; 52: 702–703
   Web of Science ®Google Scholar
• Bali Puri A., Winick J., Lowy R.J., Covell D., Eidelmann O., Walter A., Blumenthal R. Activation of vesicular stomatitis virus with cells by pretreatment at low pH. J. Biol. Chem. 1988; 263: 4749–4753
   PubMedGoogle Scholar
• Blumenthal R. Membrane fusion. Curr. Top. Membr. Trans. 1987; 29: 203–254
   Web of Science ®Google Scholar
• Blumenthal R., Bali Puri A., Walter A., Covell D., Eidelmann O. pH dependent fusion of vesicular stomatitis virus with Vero cells. J. Biol. Chem. 1987; 262: 13614–13619
   PubMed Web of Science ®Google Scholar
• Cirone M., Angeloni A., Zompetta C., Venanzoni M., Torrisi M.R., Frati L., Faggioni A. Epstein Barr virus internalization and infectivity are blocked by selective protein kinase C inhibitors. Int. J. Cancer 1990; 45: 1–4
   PubMedGoogle Scholar
• Dugas B., Delfraisy J., Calenda A., Peuchmaur M., Wallon C., Rannou M., Galanaud T. Activation and infection of B cells by Epstein Barr virus. Role of calcium mobilization and of protein kinase C translocation. J. Immunol. 1988; 141: 4344–4351
   PubMedGoogle Scholar
• Epstein M.B., Achong A.N., Barr Y. Virus particles in cultured lymphoblasts from Burkitt's lymphoma. Lancet 1964; 1: 702–703
   PubMed Web of Science ®Google Scholar
• Faggioni A., Zompetta C., Grimaldi S., Barile G., Frati L., Lazdins J. Calcium modulation activates Epstein Barr virus genome in latently infected cells. Science 1986; 232: 1554–1556
   PubMed Web of Science ®Google Scholar
• Fingerorth J., Weiss J., Tedder T., Strominger J., Bird P., Fearon D. Epstein Barr virus receptor on human B lymphocytes is the C3d receptor CR2. Proc. Natl. Acad. Sci. USA 1984; 81: 4510–4516
   PubMedGoogle Scholar
• Fields A.P., Bednarik D.P., Hess A., May W.S. Human immunodeficiency virus induces phosphorilation of its cell surface receptor. Nature (Lond.) 1988; 33: 278–280
   Google Scholar
• Grimaldi S., Verna R., Puri A., Morris S.J., Blumenthal R. Fusion of vesicular stomatitis virus with human red blood cells membranes: The role of phospholipids distribution. Adv. Biotechnol. Membr. Ion Transp. 1988; 51: 197–211
   Google Scholar
• Helenius A., Marsh M., White J. Inhibition of Semliki forest virus penetration by lysosomotropic weak bases. J. Gen. Virol. 1982; 58: 47–61
   PubMedGoogle Scholar
• Hermann A., Clague M.J., Puri A., Morris S.J., Blumenthal R., Grimaldi S. Effect of erythrocyte transbilayer distribution on fusion with vesicular stromatitis virus. Biochemistry 1990; 29: 4054–4058
   PubMed Web of Science ®Google Scholar
• Hoekstra D., de Boer T., Klappe K., Wilschut J. Fluorescent methods for measuring the kinetics of fusion between biological membranes. Biochemistry 1984; 23: 5675–5681
   PubMed Web of Science ®Google Scholar
• Lazdins J., Zompetta C., Grimaldi S., Barile G., Venanzoni M., Frati L., Faggioni A. TPA induction of Epstein Barr virus early antigens in Raji cells is blocked by selective protein kinase C inhibitors. Int. J. Cancer 1987; 40: 846–849
   PubMedGoogle Scholar
• Marsh M., Helenius A. Virus entry into animal cells. Adv. Virus Res. 1989; 36: 107–141
   PubMed Web of Science ®Google Scholar
• Miller N., Hutt Fletcher L.M. A monoclonal antibody to glycoprotein gp 85 inhibits fusion but not attachment of Epstein Barr virus. J. Virol. 1988; 62: 2360–2372
   Web of Science ®Google Scholar
• Nemerow G.R., Cooper N.R. Early events in infection of human B lymphocytes by Epstein Barr virus: Internalization process. Virology 1984; 132: 186–196
   PubMedGoogle Scholar
• Nemerow G.R., Wolfort R., McNaughton M., Cooper N. Identification and characterization of the Epstein Barr Virus receptor on human B lymphocytes and its relationship to the C3d complement receptor CR2. J. Virol. 1985; 55: 347–351
   PubMed Web of Science ®Google Scholar
• Nemerow G.R., Mold C., Schwenid V.K., Tallefson V., Cooper N.R. Identification of gp 350 as the viral glycoprotein mediating attachment of Epstein Barr virus (EBV) to the EBV-C3d complement receptor (Cr2). J. Virol. 1987; 55: 347–351
   Google Scholar
• Pulvertaft R.J.V. Cytology of Burkitt's tumor (African lymphoma). Lancet 1964; i: 238–240
   Google Scholar
• Seigneurin J.M., Vuillaume M., Lenoir G., De-Thè G. Replication of Epstein Barr virus: Ultrastructural and immuno fluorescent studies of P3HR1-superinfected Raji cells. J. Virol. 1977; 24: 836–845
   PubMedGoogle Scholar
• Tanner J., Weiss J., Fearon D., Whang Y., Kieff E. Epstein Barr virus gp 350/220 binding to the B lymphocyte C3d receptor mediates adsorption, capping and endocytosis. Cell 1987; 50: 203–213
   PubMed Web of Science ®Google Scholar
• Wells A., Koide N., Klein G. Two large virion envelope glycoproteins mediate Epstein Barr virus binding to receptor positive cells. J. Virol. 1982; 41: 286–297
   PubMed Web of Science ®Google Scholar
• White J., Kielian M., Helenius A. Membrane fusion proteins of enveloped viruses. Q. Rev. Biophys. 1983; 16: 151–195
   PubMed Web of Science ®Google Scholar